QT Imaging Holdings, Inc. (QTI)

QT Imaging Holdings, Inc. (QTI) Healthcare & Pipeline Overview

QT Imaging Holdings, Inc. specializes in automated breast imaging systems, offering high-resolution transmission ultrasound technology. Their QT Ultrasound Breast Scanner provides unique reflection and transmission mode images, positioning them as an innovator in the medical devices sector focused on improving breast cancer detection and diagnostics.

What Is the Investment Thesis for QTI?

QT Imaging Holdings, Inc. presents a compelling investment thesis centered on its innovative QT Ultrasound technology and its potential to disrupt the breast imaging market. With a market capitalization of $107.99M, the company operates with a negative P/E ratio of -4.46 and a negative profit margin of -111.4%, indicating its growth stage and investment in R&D. Key value drivers include the increasing demand for more accurate and comfortable breast screening methods, particularly for women with dense breast tissue. Growth catalysts include potential FDA approvals for expanded applications of the QT Ultrasound Breast Scanner and strategic partnerships with healthcare providers. However, potential risks include competition from established players in the medical imaging market and the need for significant capital to fund ongoing research and commercialization efforts. The company's gross margin of 45.4% suggests potential for profitability as it scales its operations.

Based on FMP financials and quantitative analysis

QTI Key Highlights

• Market Cap of $107.99M reflects investor valuation of QT Imaging's potential in the breast imaging market.
• Gross Margin of 45.4% indicates the company's ability to generate revenue above the cost of goods sold, suggesting potential for future profitability.
• Negative P/E Ratio of -4.46 signifies that the company is currently not profitable, common for growth-stage companies investing heavily in R&D.
• Profit Margin of -111.4% highlights the company's significant investments in research and development and commercialization efforts.
• Beta of -0.11 suggests the stock is less volatile than the market, potentially offering stability in turbulent times.

Who Are QTI's Competitors?

QTI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are QTI's Key Strengths?

• Proprietary QT Ultrasound technology.
• High-resolution transmission ultrasound imaging.
• Potential for improved breast cancer detection.
• More comfortable imaging experience for patients.

What Are QTI's Weaknesses?

• Limited market penetration.
• Need for significant capital investment.
• Reliance on regulatory approvals.
• Small number of employees.

What Could Drive QTI Stock Higher?

• Potential FDA approvals for expanded applications of QT Ultrasound Breast Scanner.
• Strategic partnerships with hospitals and imaging centers to increase adoption.
• Clinical studies demonstrating improved breast cancer detection rates.
• International expansion into new markets.

What Are the Key Risks for QTI?

• Financial-distress signal — its Altman Z-Score of 0.18 sits in the distress zone (elevated bankruptcy risk).
• Competition from established players in the medical imaging market.
• Technological obsolescence of QT Ultrasound technology.
• Changes in healthcare regulations affecting reimbursement rates.
• Need for significant capital to fund ongoing research and commercialization efforts.

What Are the Growth Opportunities for QTI?

• Expanding Clinical Applications: QT Imaging has the opportunity to expand the clinical applications of its QT Ultrasound Breast Scanner beyond initial breast cancer screening. This includes using the technology for monitoring treatment response, assessing breast implant integrity, and evaluating other breast-related conditions. The market for these expanded applications could significantly increase the company's revenue potential. Timeline: Ongoing.
• Strategic Partnerships: Forming strategic partnerships with hospitals, imaging centers, and oncology clinics can accelerate the adoption of QT Imaging's technology. These partnerships can provide access to established patient networks and facilitate the integration of QT Ultrasound into existing clinical workflows. The market for strategic partnerships is driven by the need for healthcare providers to offer advanced imaging solutions. Timeline: Ongoing.
• International Expansion: QT Imaging can pursue international expansion opportunities, particularly in regions with high breast cancer incidence and limited access to advanced screening technologies. This includes targeting markets in Europe, Asia, and Latin America. The global market for breast imaging is substantial, offering significant growth potential. Timeline: 2027-2030.
• Technological Advancements: Continuous investment in research and development can lead to further technological advancements in QT Ultrasound technology. This includes improving image resolution, reducing scan time, and developing new imaging modalities. The market for advanced imaging technologies is driven by the demand for more accurate and efficient diagnostic tools. Timeline: Ongoing.
• Direct-to-Consumer Marketing: QT Imaging can explore direct-to-consumer marketing strategies to raise awareness of its technology and drive demand for QT Ultrasound Breast Scans. This includes online advertising, social media campaigns, and partnerships with women's health organizations. The market for direct-to-consumer healthcare services is growing, driven by increasing consumer empowerment and access to information. Timeline: 2027-2028.

What Opportunities Does QTI Have?

• Expanding clinical applications of QT Ultrasound.
• Strategic partnerships with healthcare providers.
• International expansion into new markets.
• Direct-to-consumer marketing initiatives.

What Threats Does QTI Face?

• Competition from established imaging technologies.
• Technological obsolescence.
• Changes in healthcare regulations.
• Economic downturn affecting healthcare spending.

What Are QTI's Competitive Advantages?

• Proprietary QT Ultrasound technology.
• Patents protecting key innovations.
• First-mover advantage in transmission ultrasound breast imaging.
• Growing clinical evidence supporting the effectiveness of QT Ultrasound.

What Does QTI Do?

QT Imaging Holdings, Inc., founded in 2011 and based in Novato, California, is a medical device company focused on revolutionizing breast imaging through its proprietary QT Ultrasound technology. The company develops, manufactures, and markets the QT Ultrasound Breast Scanner, an automated system designed to produce high-resolution transmission ultrasound images of the breast. This technology offers both reflection-mode and transmission-mode imaging, providing clinicians with a comprehensive view of breast tissue. QT Imaging aims to improve the accuracy and comfort of breast cancer screening, particularly for women with dense breast tissue, where traditional mammography can be less effective. The company's focus is on early detection and improved diagnostic capabilities, potentially reducing the need for invasive biopsies and enhancing patient outcomes. QT Imaging continues to invest in research and development to expand the applications of its ultrasound technology and broaden its market reach within the medical imaging industry.

What Products and Services Does QTI Offer?

• Develops and manufactures the QT Ultrasound Breast Scanner.
• Offers high-resolution transmission ultrasound imaging technology.
• Provides both reflection-mode and transmission-mode breast images.
• Focuses on improving breast cancer screening accuracy.
• Aims to reduce the need for invasive biopsies.
• Offers a more comfortable breast imaging experience.

How Does QTI Make Money?

• Sales of QT Ultrasound Breast Scanner systems to hospitals and imaging centers.
• Service and maintenance contracts for installed systems.
• Potential for per-scan revenue model.
• Licensing of QT Ultrasound technology for other applications.

What Industry Does QTI Operate In?

QT Imaging Holdings, Inc. operates within the medical devices industry, specifically targeting the breast imaging market. This market is characterized by a growing demand for more accurate, comfortable, and accessible screening methods, particularly for women with dense breast tissue. The competitive landscape includes established players offering mammography, ultrasound, and MRI technologies. QT Imaging aims to differentiate itself through its proprietary QT Ultrasound technology, which provides high-resolution transmission ultrasound images. The global breast imaging market is projected to reach billions of dollars in the coming years, driven by increasing breast cancer incidence and rising awareness of early detection.

Who Are QTI's Key Customers?

• Hospitals and medical centers.
• Imaging centers and radiology clinics.
• Oncology clinics and breast cancer centers.
• Research institutions.

FY2026 estForward Outlook

Wall Street analysts project QT Imaging Holdings, Inc. revenue of about $39.2M for fiscal 2026, with EPS near $-0.53.

F-Score 4/9Financial Health

QT Imaging Holdings, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.18 places it in the distress zone, a signal of elevated financial risk.

Key Financial Metrics

Return on assets is -60.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -8.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.49 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -24.1%, the inverse of the P/E and a quick read on earnings relative to price.

QT Imaging Holdings, Inc. (QTI) Valuation Context

Valued at $107.99M, QTI is classified as a micro-cap stock. Relative to its peer group, QTI's quantitative score of 24/100 is below the peer average of 52/100.

Company Profile

QT Imaging Holdings, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Novato, US. The company is led by CEO Raluca Dinu. QTI has traded publicly since 2024.

QTI Financials

QTI Latest News

QTI Analyst Consensus

QTI MoonshotScore

QTI Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources